Venture Capital Funding Survey, First Quarter 2014
VENTURE CAPITAL FUNDING, FIRST QUARTER 2014 This is a listing of many of the Bay Area firms that received venture capital financing between Jan. 1 and March 31, 2014. Most of the data was compiled from a survey conducted by PricewaterhouseCoopers, Thomson Venture Economics and the National Venture Capital Association in conjunction with the Mercury News. In the case of some investments there may have been other participants in the round who are not credited. Also, the amounts listed may not include all venture funding the company received during the quarter. *Indicates this is a seed or first-round infusion of money from venture capitalists. These companies may have received money previously from other investors and aren't necessarily startups.
BIOTECHNOLOGY / HEALTH Name 3-V Biosciences
City Menlo Park
Stage Early Stage
Amount Investors $4,749,000 Kleiner Perkins Caufield & Byers, New Enterprise Associates
Description Therapeutics that modulate pathways for the treatment of oncology
Acerta Pharma
San Carlos
Startup/Seed
$13,000,000 Frazier Healthcare, undisclosed firm
Treatments for cancer and autoimmune diseases
Afferent Pharmaceuticals
San Mateo
Early Stage
$6,300,000 Domain Associates, undisclosed firm
Altura Medical
Menlo Park
Expansion
$4,000,000 SV Life Sciences Medical devices Advisers, undisclosed firm
Atara Biotherapeutics
Brisbane
Early Stage
$13,500,000 Amgen, Domain Associates, Duff Ackerman & Goodrich, Kleiner Perkins Caufield & Byers, undisclosed firms
Bell Biosystems
Palo Alto
Expansion
$2,058,000 Undisclosed firm
Stem-cell research technology tools
BioTrace Medical*
San Mateo
Startup/Seed
$3,500,000 Okapi Venture Capital, undisclosed firm
Health care industry
Cardiva Medical
Sunnyvale
Later Stage
$3,300,000 PTV Sciences
Medical device company
Cerebrotech Medical Systems
Pleasanton
Early Stage
$2,000,000 TriStar Technology Ventures, undisclosed firm
Technology for non-invasive monitoring of patients
Cerephex
Los Gatos
Early Stage
$9,820,000 Undisclosed firm, Versant Ventures
Medical device company
CogENT Therapeutics*
Hayward
Early Stage
$1,100,000 Band of Angels, undisclosed firm
Medical device company
Coherus Biosciences
Redwood City
Early Stage
$5,225,000 Sofinnova Ventures
Clinical-stage, biosimilar biologics company
Page 1 of 25
Clinical-stage biopharmaceutical company
Drug development company